Filter
670
Text search:
pharmaceutical
industry
Featured
Recommendations
48
New Publications
160
Language
Document type
No document type
301
Studies & Reports
170
Guidelines
107
Strategic & Response Plan
40
Manuals
27
Fact sheets
8
Situation Updates
7
Training Material
2
Brochures
2
Resource Platforms
2
Infographics
2
Online Courses
2
Countries / Regions
Global
34
India
31
Kenya
30
South Africa
21
Ethiopia
16
Uganda
14
Sierra Leone
13
Nepal
13
Nigeria
12
Ghana
12
Bangladesh
11
Namibia
9
Africa
9
Philippines
8
Tanzania
8
Western and Central Europe
8
Zimbabwe
7
Zambia
7
Syria
7
Myanmar / Burma
7
Latin America and the Carribbean
7
Rwanda
6
Indonesia
6
West and Central Africa
6
Malawi
5
Ukraine
5
Botswana
5
Mozambique
4
South–East Asia Region
4
Asia
4
Eastern Europe
4
Pakistan
3
Thailand
3
Eswatini/ Swaziland
3
Lesotho
3
East and Southern Africa
3
Liberia
2
Senegal
2
Haiti
2
Jordan
2
Afghanistan
2
Cambodia
2
China
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Venezuela
2
Laos
2
Vietnam
2
Burkina Faso
1
Congo, Democratic Republic of
1
Mali
1
USA
1
Saudi Arabia
1
South Sudan
1
Germany
1
Lebanon
1
Egypt
1
Sudan
1
Benin
1
Central African Republic
1
Brazil
1
Colombia
1
Sri Lanka
1
Chile
1
Western Pacific Region
1
Albania
1
Tajikistan
1
Lithuania
1
Moldova
1
Iran
1
Kyrgyzstan
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
242
Clinical Guidelines
37
Public Health
26
Key Resources
25
Pharmacy & Technologies
15
Women & Child Health
10
Capacity Building
4
Annual Report MEDBOX
2
Toolboxes
AMR
113
Pharmacy
62
COVID-19
54
HIV
30
Mental Health
30
Planetary Health
22
Global Health Education
20
NCDs
19
TB
17
NTDs
16
Rapid Response
15
Health Financing Toolbox
15
Ebola & Marburg
10
Conflict
8
Caregiver
7
2.0 Rapid Response
7
Specific Hazards
6
Malaria
4
Disability
3
Refugee
3
Polio
2
Zika
2
Cholera
1
Natural Hazards
1
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t
...
Antimicrobial resistance (AMR) is occurring everywhere in the world, compromising the ability to treat infectious diseases, as well as undermining many other advances in health and medicine. Underlying factors that drive AMR include; weak or absent surveillance and monitoring systems, inadequate sys
...
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’.
The guidance should be read alon
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight
...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing
...
English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge,
...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically
...
